|
π
|
Broad targeting of resistance to apoptosis in cancer
39 auth.
R. Mohammad,
I. Muqbil,
Leroy Lowe,
C. Yedjou,
H. Hsu,
Liang-Tzung Lin,
M. Siegelin,
C. Fimognari,
Nagi B. Kumar,
Q. Dou,
Huanjie Yang,
A. Samadi,
G. Russo,
C. Spagnuolo,
S. Ray,
...
M. Chakrabarti,
J. MorrΓ©,
H. Coley,
K. Honoki,
H. Fujii,
A. Georgakilas,
A. Amedei,
E. Niccolai,
A. Amin,
S. Ashraf,
W. Helferich,
Xujuan Yang,
Chandra S Boosani,
G. Guha,
D. Bhakta,
M. Ciriolo,
K. Aquilano,
Sophie S. Chen,
S. Mohammed,
W. Keith,
A. Bilsland,
D. Halicka,
S. Nowsheen,
A. Azmi
|
9 |
2015 |
9
π
|
|
π
|
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
180 auth.
Keith I Block,
C. Gyllenhaal,
Leroy Lowe,
A. Amedei,
A. Amin,
A. Amin,
K. Aquilano,
J. Arbiser,
Alexandra Arreola,
A. Arzumanyan,
S. Ashraf,
A. Azmi,
F. Benencia,
D. Bhakta,
A. Bilsland,
...
A. Bishayee,
S. Blain,
Penny B. Block,
Chandra S Boosani,
T. Carey,
A. Carnero,
M. Carotenuto,
S. Casey,
M. Chakrabarti,
Rupesh Chaturvedi,
G. Chen,
Helen Chen,
Sophie S. Chen,
Y. Chen,
Beom K. Choi,
M. Ciriolo,
H. Coley,
A. Collins,
Marisa Connell,
S. Crawford,
C. Curran,
C. Dabrosin,
G. Damia,
S. Dasgupta,
R. Deberardinis,
W. Decker,
P. Dhawan,
A. Diehl,
Jin-Tang Dong,
Q. Dou,
J. Drew,
E. Elkord,
B. El-Rayes,
M. Feitelson,
D. Felsher,
L. Ferguson,
C. Fimognari,
G. Firestone,
C. Frezza,
H. Fujii,
M. Fuster,
D. Generali,
A. Georgakilas,
F. Gieseler,
M. Gilbertson,
Michelle F. Green,
Brendan H Grue,
G. Guha,
D. Halicka,
W. Helferich,
P. Heneberg,
P. Hentosh,
M. Hirschey,
L. Hofseth,
R. Holcombe,
K. Honoki,
H. Hsu,
Gloria S. Huang,
L. Jensen,
W. Jiang,
L. Jones,
P. Karpowicz,
W. Keith,
Sid P. Kerkar,
G. Khan,
M. Khatami,
Y. Ko,
O. Kucuk,
Rob J. Kulathinal,
Nagi B. Kumar,
B. Kwon,
A. Le,
M. Lea,
Ho-Yyoung Lee,
T. Lichtor,
Liang-Tzung Lin,
J. Locasale,
B. Lokeshwar,
V. Longo,
C. Lyssiotis,
K. MacKenzie,
M. Malhotra,
M. Marino,
M. MartΓnezβChantar,
A. Matheu,
C. Maxwell,
Eoin McDonnell,
A. Meeker,
Mahya Mehrmohamadi,
K. Mehta,
G. Michelotti,
R. Mohammad,
S. Mohammed,
D. MorreΜ,
V. Muralidhar,
I. Muqbil,
M. Murphy,
G. Nagaraju,
R. Nahta,
E. Niccolai,
S. Nowsheen,
C. Panis,
F. Pantano,
Virginia R. Parslow,
G. Pawelec,
P. Pedersen,
Brad Poore,
Deepak Poudyal,
S. Prakash,
M. Prince,
L. Raffaghello,
J. Rathmell,
W. Rathmell,
S. Ray,
J. Reichrath,
Sarallah Rezazadeh,
D. Ribatti,
L. Ricciardiello,
R. Robey,
F. Rodier,
H. Rupasinghe,
G. Russo,
E. Ryan,
A. Samadi,
I. SΓ‘nchez-GarcΓa,
A. Sanders,
D. Santini,
M. Sarkar,
T. Sasada,
N. Saxena,
R. Shackelford,
H. Shantha Kumara,
D. Sharma,
D. Shin,
D. Sidransky,
M. Siegelin,
E. Signori,
Neetu Singh,
S. Sivanand,
D. SlΓva,
C. Smythe,
C. Spagnuolo,
D. Stafforini,
J. Stagg,
P. Subbarayan,
Tabetha Sundin,
Wamidh H. Talib,
S. Thompson,
P. Tran,
H. Ungefroren,
M. V. Vander Heiden,
V. Venkateswaran,
D. Vinay,
P. Vlachostergios,
Zongwei Wang,
K. Wellen,
R. Whelan,
E. Yang,
Huanjie Yang,
Xujuan Yang,
P. Yaswen,
C. Yedjou,
Xin Yin,
Jiyue Zhu,
M. Zollo
|
7 |
2015 |
7
π
|
|
π¦
|
Epidermal growth factor receptor mutations in lung adenocarcinoma
M. Siegelin,
A. Borczuk
|
7 |
2014 |
7
π¦
|
|
π
|
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
8 auth.
H. Strobel,
T. Baisch,
R. Fitzel,
Katharina Schilberg,
M. Siegelin,
G. Karpel-Massler,
...
K. Debatin,
M. Westhoff
|
7 |
2019 |
7
π
|
|
π¬
|
Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells.
J. C. Ghosh,
M. Siegelin,
T. Dohi,
D. Altieri
|
7 |
2010 |
7
π¬
|
|
π¦
|
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.
9 auth.
M. Siegelin,
T. Dohi,
C. Raskett,
Gregory Orlowski,
C. Powers,
C. Gilbert,
...
A. Ross,
J. Plescia,
D. Altieri
|
7 |
2011 |
7
π¦
|
|
π¦
|
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
M. Siegelin,
D. Reuss,
A. Habel,
A. Rami,
A. von Deimling
|
7 |
2009 |
7
π¦
|
|
π
|
Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
7 auth.
K. Plaschke,
Juergen Kopitz,
M. Siegelin,
R. Schliebs,
M. Ε alkoviΔ-PetriΕ‘iΔ,
P. Riederer,
...
S. Hoyer
|
6 |
2010 |
6
π
|
|
π’
|
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
19 auth.
T. Nguyen,
Yiru Zhang,
E. Shang,
C. Shu,
Consuelo Torrini,
Junfei Zhao,
E. Bianchetti,
Angeliki Mela,
N. Humala,
A. Mahajan,
...
A. Harmanci,
Zhengdeng Lei,
M. Maienschein-Cline,
C. Quinzii,
M. Westhoff,
G. Karpel-Massler,
J. Bruce,
P. Canoll,
M. Siegelin
|
6 |
2020 |
6
π’
|
|
π
|
Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up
9 auth.
T. Gaiser,
H. Kutzner,
G. Palmedo,
M. Siegelin,
T. Wiesner,
T. Bruckner,
...
W. Hartschuh,
A. Enk,
M. Becker
|
6 |
2010 |
6
π
|
|
π
|
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
59 auth.
Jana Biermann,
Johannes C. Melms,
A. D. Amin,
Yiping Wang,
Lindsay A. Caprio,
Alcida Karz,
Somnath Tagore,
Irving Barrera,
Miguel A. Ibarra-Arellano,
M. Andreatta,
Benjamin T. Fullerton,
Kristjan H. Gretarsson,
Varun Sahu,
Vaibhav Mangipudy,
T. Nguyen,
...
A. Nair,
Meri Rogava,
P. Ho,
P. Koch,
M. Banu,
N. Humala,
A. Mahajan,
Zachary H. Walsh,
Shivem B. Shah,
D. Vaccaro,
Blake M. Caldwell,
Michael Mu,
Florian WuΜnnemann,
M. Chazotte,
Simon Berhe,
Adrienne M. Luoma,
Joseph Driver,
M. Ingham,
Shaheer Khan,
Suthee Rapisuwon,
C. Slingluff,
T. Eigentler,
M. RΓΆcken,
R. Carvajal,
M. Atkins,
M. Davies,
Albert S. Agustinus,
S. Bakhoum,
E. Azizi,
M. Siegelin,
Chao Lu,
Santiago J. Carmona,
H. Hibshoosh,
A. Ribas,
P. Canoll,
J. Bruce,
W. Bi,
Praveen Agrawal,
D. Schapiro,
E. Hernando,
Evan Z. Macosko,
Fei Chen,
G. Schwartz,
Benjamin Izar
|
6 |
2022 |
6
π
|
